Purification of the human complement control protein C3b inactivator.
about
Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosusInteractions between human complement components factor H, factor I and C3bInhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranesA cluster of positively charged amino acids in the C4BP alpha-chain is crucial for C4b binding and factor I cofactor function.Acquisition of complement inhibitor serine protease factor I and its cofactors C4b-binding protein and factor H by Prevotella intermedia.Novel scabies mite serpins inhibit the three pathways of the human complement system.Zinc binding to the Tyr402 and His402 allotypes of complement factor H: possible implications for age-related macular degeneration.Third component of human complement: localization of the internal thiolester bond.Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.Structural stability and heat-induced conformational change of two complement inhibitors: C4b-binding protein and factor HZinc-induced self-association of complement C3b and Factor H: implications for inflammation and age-related macular degeneration.Analysis of genes coding for CD46, CD55, and C4b-binding protein in patients with idiopathic, recurrent, spontaneous pregnancy lossNutritional supplements in age-related macular degeneration.The alternative pathway of complement.Dissecting the regions of virion-associated Kaposi's sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding.Human complement component C4. Structural studies on the fragments derived from C4b by cleavage with C3b inactivator.Degradation of human complement component C4b in the presence of the C4b-binding protein-protein S complex.The amino-terminal module of the C4b-binding protein alpha-chain is crucial for C4b binding and factor I-cofactor function.Expression and characterization of a recombinant C4b-binding protein lacking the beta-chain.Autolytic fragmentation of complement components C3 and C4 under denaturing conditions, a property shared with alpha 2-macroglobulin.Purification of human C3b inactivator by monoclonal-antibody affinity chromatography.Amino acid sequence around the thiol and reactive acyl groups of human complement component C4.CNBr cleavage of the light chain of human complement factor I and alignment of the fragments.Purification of human vitamin K-dependent protein S and its limited proteolysis by thrombinMolecular modelling of the domain structure of factor I of human complement by X-ray and neutron solution scattering.Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38kDa tryptic fragment of factor H.Enzymic assay of C3b receptor on intact cells and solubilized cells.Non-enzymic activation of the covalent binding reaction of the complement protein C3.The covalent-binding reaction of complement component C3.The separation of functionally distinct forms of the third component of human complement (C3).The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.Mutations in alpha-chain of C4BP that selectively affect its factor I cofactor function.The Kaposi's sarcoma-associated herpesvirus complement control protein mimics human molecular mechanisms for inhibition of the complement system.Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.Generation of anaphylatoxin activity related to C3a, by treatment of human serum with the nitrogen nucleophile N2H4 or the chaotrope KSCN.Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies.
P2860
Q24302256-F7E0A0A0-5A0F-4B0B-AE50-87064A88A2E6Q24530290-6B41D4B6-766D-447D-B988-1F0F51E4DFFAQ28610983-D25D6AB8-DFCF-4194-850F-E993DB494682Q33845398-2FCCE378-4863-4E15-8CE3-92476C805D9AQ34238754-CDD83E2F-42D9-4114-A9A6-A63C4780212BQ34336401-E29623E4-BBEB-45C8-8361-4131AE24BAC4Q34976109-504B16B7-953C-4878-A413-B0AA28F1328DQ36281685-10677C8C-A390-4DE2-891A-4D903DAEABCDQ36347257-E4A67D81-49DA-4C10-85ED-1759A8E9DD5AQ36348868-B64F6237-107D-4135-9CE6-BFCA5522DD9AQ36349022-CB6F3CD8-4831-4F4B-830A-372F7C0A2DC3Q36526549-D4DA897D-DBD0-4DB3-9C49-CCCF17CABC65Q36967403-510D30F3-4F1F-43F5-ABB4-083D20EABF43Q37139451-D22BA566-B10C-4F77-B82A-9DE98699278BQ38317289-213EF7F3-1EF1-4544-8039-6E2ABACE1640Q40118346-565B4529-4627-48A6-91D4-F9EA262E625AQ41810495-52EFDE83-F73B-462B-BE9F-D749EFCF669FQ41854854-C7364BB1-05C7-4E28-AF2C-B033ECF548ABQ41889954-76696F1C-1002-4616-BA7E-5F6A38CC19CBQ41966440-313B567E-DBB6-4B80-83C1-B3BD142586F5Q41985371-ADDE7C49-F314-435E-8119-5376C3EE38E5Q42018523-8557A08F-2378-446E-BE9A-1002F5FA432EQ42113655-846828DF-E6E3-4B97-8702-F6E88E73CA88Q42119474-DA48027E-35EC-406A-9BAE-551F404DB901Q42133761-ACC20687-9863-4400-9872-EEBB29CE34EBQ42167364-BCCECA3D-AF4B-4717-B369-73E0FEA7FB19Q42814747-3FD8BB87-3D95-4664-9677-18205948E980Q42848520-AB9A26BE-12E5-4D58-9145-E686E9D1FBA9Q42869526-F409CC31-6BFD-442A-9AE1-04C57B2B8CE5Q42869732-56259FF7-60C9-4304-8BC0-73C468C91787Q42876404-EA2D32A0-FC59-4E15-A08F-ED012A5564D3Q42883126-5D236472-3468-492C-BF87-4E98C5AC855FQ43830771-B81E7108-A587-4BBE-AC29-E01CC34ADF0BQ44534312-9443CE30-3217-4B52-8CE7-FAB19AF20D9CQ45013859-EDCA7456-6C87-4C76-B84E-50D6617BB8C4Q46388632-EF90CC67-AA6F-45ED-8A9F-BB42A0A8845AQ46780129-DCB28F4C-C4FD-4152-A629-6D99228C0845Q51794990-56C37BBA-0544-4089-9BE2-856CF0D03D9B
P2860
Purification of the human complement control protein C3b inactivator.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
Purification of the human complement control protein C3b inactivator.
@en
type
label
Purification of the human complement control protein C3b inactivator.
@en
prefLabel
Purification of the human complement control protein C3b inactivator.
@en
P2860
P356
P1433
P1476
Purification of the human complement control protein C3b inactivator.
@en
P2093
Crossley LG
P2860
P304
P356
10.1042/BJ1910173
P407
P577
1980-10-01T00:00:00Z